NTLA (intelliatx.com) Earnings growth in current year

Official company branding of Intellia Corp (NTLA)

Stable management is confidently steering key CRISPR projects toward regulatory approval. The YoY EPS trend illustrates financial resilience, with the metric currently standing at 12.80. Intellia Therapeutics (NTLA) focuses on developing one-time in vivo therapies for rare pathologies. Fundamental patents and partnerships with industry behemoths protect the business from dumping, cementing its leadership in gene editing.

NTLA (intelliatx.com) Net earnings per share growth this year history from 07/04/2022 to 11/17/2026

Financial and market metric breakdowns for Intellia Corp (NTLA)

- current quotes and average value forecast:
Basic company analysis:Intellia (NTLA)
Manufactured products of Intellia

The long-term reliability of Intellia Therapeutics (NTLA) is determined by its ability to scale earnings per share, which allows for an assessment of capital efficiency via the annual trajectory of EPS changes. This indicator measures the percentage shift in EPS relative to the previous year, reflecting the company's financial stability while implementing its strategy to create radical drugs for the therapy of genetic pathologies using in vivo gene editing.

Direct competitors

Tempus AI, Inc (TEM) - Earnings growth in current year|Earnings per share growth in current year Qiagen|IONS: Earnings per share increase in current year|Net earnings per share growth this year RGEN (Repligen)|Expected net earnings per share growth this year Avidity Biosciences Inc|Earnings growth in current year CRSP (crisprtx.com)|WGS: Earnings per share growth this year|RARE: Net earnings per share growth this year|Earnings per share trend in current year BEAM|Sarepta (SRPT) - Earnings per share growth in current year|TWST - Expected net earnings per share growth this year|Earnings per share growth in current year 10x Genomics, Inc.|Earnings per share growth rate in current year Stoke Therapeutics STOK|Earnings growth in current year BLFS|Wave Life Sciences - Earnings per share growth this year|Earnings growth in current year MAZE (Maze Therapeutics, Inc.)|Earnings growth in current year Sionna Pharma SION|Prime Medicine Bio - Earnings growth in current year|Earnings per share increase in current year TSHA (Taysha)|QURE: Earnings growth in current year|MGTX - Expected net earnings per share growth this year|Net earnings per share growth this year RGNX|SLDB: Earnings per share increase in current year|Earnings per share growth in current year ocugen.com (OCGN)|Expected net earnings per share growth this year PacBio Corp|Earnings per share growth in current year Benitec Biopharma BNTC|DSGN: Earnings per share growth this year|RCKT - Earnings per share growth in current year|4dmoleculartherapeutics.com (FDMT) - Net earnings per share growth this year|lexeotx.com (LXEO) - Earnings per share growth in current year|Korro Bio, Inc (KRRO) - Earnings growth in current year|EDIT (editasmedicine.com) - Earnings growth in current year|Earnings per share growth this year SLN (silence-therapeutics.com)|Earnings per share growth in current year proqr.com (PRQR)|Codexis - Earnings per share growth this year|Earnings growth in current year SGMO (Sangamo Therapeutics)|Earnings growth in current year nautilus.bio NAUT|Metagenomi Inc. - Earnings growth in current year|DTIL (Precision BioSciences Inc.) - Earnings per share growth this year|GBIO: Earnings growth in current year|Earnings per share growth rate in current year Boundless Bio, Inc (BOLD)|XCUR (Exicure) - Earnings growth in current year|Net earnings per share growth this year Imunon (IMNN)|Earnings growth in current year PHIO|Mustang Bio - Earnings per share growth this year|TransCode Therapeutics, Inc. - Net earnings per share growth this year|Expected net earnings per share growth this year Bionano Genomics, Inc. (BNGO)|APDN - Earnings per share growth in current year|Earnings per share increase in current year BLUE (Bluebird Bio)|ImmunoPrecise (IPA) - Earnings per share growth in current year|OMGA: Net earnings per one share growth for the current year|Earnings per share growth in current year Singular Genomics Systems, Inc.|Earnings growth in current year Regulus Therapeutics, Inc.|Net earnings per share growth this year SYRS (Syros)|TBIO - Earnings per share growth rate in current year|Earnings per share growth in current year TRACON Pharmaceuticals, Inc. TCON|Unity Biotechnology (UBX) - Earnings per share growth rate in current year